Posts tagged Hancock Jaffe Laboratories
Hancock Jaffe Laboratories Selects bioaccess™ as CRO for its First-in-Human VenoValve® Study in Colombia
Hancock Jaffe Laboratories Selects bioaccess™ as CRO for its First-in-Human VenoValve® Study in Colombia

Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, has selected bioaccess.™ as its contract research organization (CRO) for a first-in-human clinical trial of its VenoValve® bioprosthetic medical device. The clinical trial will be conducted at Hospital Universitario de la Fundación Santa Fé de Bogotá ("FSFB") in Bogota, Colombia. FSFB owns a 205-bed university hospital in Bogota, and was the first hospital in Colombia to receive the distinguished Joint Commission International accreditation; FSFB also boasts an academic affiliation with John’s Hopkins Medical International in Baltimore, MD.

Read More
Clinical TrialsJulio G. Martinez-ClarkHancock Jaffe Laboratories, CRO in Colombia, VenoValve, first-in-human clinical trial in ColombiaComment